[go: up one dir, main page]

AR027349A1 - Derivados de amidas heterociclicas - Google Patents

Derivados de amidas heterociclicas

Info

Publication number
AR027349A1
AR027349A1 ARP010100483A ARP010100483A AR027349A1 AR 027349 A1 AR027349 A1 AR 027349A1 AR P010100483 A ARP010100483 A AR P010100483A AR P010100483 A ARP010100483 A AR P010100483A AR 027349 A1 AR027349 A1 AR 027349A1
Authority
AR
Argentina
Prior art keywords
amidas
heterociclic
derivatives
useful
compound
Prior art date
Application number
ARP010100483A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of AR027349A1 publication Critical patent/AR027349A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40—Benzopyrazines
    • C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Ophthalmology & Optometry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Transplantation (AREA)
  • Vascular Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Un compuesto de formula (1) o sus sales farmacéuticamente aceptables; en la que R1, R2, R3 y R4 son como se han definido en la descripcion, util paratratar la inflamacion y otros trastornos inmunologicos.
ARP010100483A 2000-02-04 2001-02-01 Derivados de amidas heterociclicas AR027349A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US18015900P 2000-02-04 2000-02-04

Publications (1)

Publication Number Publication Date
AR027349A1 true AR027349A1 (es) 2003-03-26

Family

ID=22659425

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010100483A AR027349A1 (es) 2000-02-04 2001-02-01 Derivados de amidas heterociclicas

Country Status (37)

Country Link
US (2) US6548671B2 (es)
EP (1) EP1252154A1 (es)
JP (1) JP2003522164A (es)
KR (2) KR20020072304A (es)
CN (1) CN1398265A (es)
AP (1) AP2002002595A0 (es)
AR (1) AR027349A1 (es)
AU (1) AU2699701A (es)
BG (1) BG106922A (es)
BR (1) BR0108002A (es)
CA (1) CA2399214A1 (es)
CZ (1) CZ20022542A3 (es)
EA (2) EA200401099A1 (es)
EE (1) EE200200432A (es)
GE (1) GEP20043301B (es)
GT (1) GT200100021A (es)
HK (1) HK1050006A1 (es)
HN (1) HN2001000021A (es)
HR (1) HRP20020638A2 (es)
HU (1) HUP0204560A3 (es)
IL (1) IL150862A0 (es)
IS (1) IS6468A (es)
MA (1) MA25653A1 (es)
NO (1) NO20023675L (es)
NZ (1) NZ520075A (es)
OA (1) OA12174A (es)
PA (1) PA8511401A1 (es)
PE (1) PE20011057A1 (es)
PL (1) PL357094A1 (es)
SK (1) SK10882002A3 (es)
SV (1) SV2002000302A (es)
TN (1) TNSN01021A1 (es)
TW (1) TW200804311A (es)
UA (1) UA72789C2 (es)
UY (1) UY26568A1 (es)
WO (1) WO2001057023A1 (es)
ZA (1) ZA200206140B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002347985A1 (en) 2001-11-15 2003-06-10 Eli Lilly And Company Peroxisome proliferator activated receptor alpha agonists
SE0201980D0 (sv) * 2002-06-24 2002-06-24 Astrazeneca Ab Novel compounds
US20040087571A1 (en) * 2002-10-30 2004-05-06 Pfizer Inc Methods of using CCR1 antagonists as immunomodulatory agents
US20040097554A1 (en) * 2002-10-30 2004-05-20 Pfizer Inc Heteroaryl-hexanoic acid amide derivatives as immonomodulatory agents
US8017781B2 (en) * 2005-11-15 2011-09-13 Vertex Pharmaceuticals Incorporated Azaindazoles useful as inhibitors of kinases
CN1971279B (zh) * 2006-12-06 2011-05-18 华中农业大学 喹噁啉-2-羧酸残留的酶联免疫检测方法及试剂盒
HRP20231682T1 (hr) 2017-03-13 2024-03-29 Raqualia Pharma Inc. Derivati tetrahidrokinolina kao antagonisti p2x7 receptora

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL88619A0 (en) * 1987-12-15 1989-07-31 Pfizer Non-peptidic renin inhibitors
EP0374098A3 (de) * 1988-12-15 1991-05-02 Ciba-Geigy Ag Retrovirale Proteasehemmer
PT100865A (pt) 1991-09-11 1994-01-31 Smithkline Beckman Corp Isosteros de peptido contendo um heterociclo, processo de preparacao dos mesmos seus intermediarios, uso e composicoes farmaceuticas
EP0628035A4 (en) * 1992-02-26 1995-03-29 Smithkline Beecham Corp RETROVIRAL PROTEASE INHIBITORS.
ES2180600T3 (es) * 1994-10-19 2003-02-16 Novartis Ag Eteres de isosteros substrato de aspartato proteasa antivirales.
JP3771591B2 (ja) * 1997-02-26 2006-04-26 ファイザー・インク ヘテロアリールヘキサン酸アミド誘導体、それらの製造法およびそのＣＣＲ１レセプターと結合するＭＩＰ−１αの選択的な阻害剤としてのそれらの使用
TR200002248T2 (tr) * 1998-02-05 2000-12-21 Pfizer Products Inc. Yeni dihidroksiheksanoik asit türevleri

Also Published As

Publication number Publication date
CA2399214A1 (en) 2001-08-09
HUP0204560A3 (en) 2005-03-29
US6689886B2 (en) 2004-02-10
GT200100021A (es) 2001-01-31
PE20011057A1 (es) 2001-10-22
CZ20022542A3 (cs) 2003-08-13
HN2001000021A (es) 2001-07-08
CN1398265A (zh) 2003-02-19
WO2001057023A1 (en) 2001-08-09
PL357094A1 (en) 2004-07-12
EA200200749A1 (ru) 2002-12-26
US6548671B2 (en) 2003-04-15
HUP0204560A2 (en) 2003-05-28
IS6468A (is) 2002-07-11
SK10882002A3 (sk) 2003-10-07
EP1252154A1 (en) 2002-10-30
TNSN01021A1 (fr) 2005-11-10
IL150862A0 (en) 2003-02-12
HRP20020638A2 (en) 2004-12-31
SV2002000302A (es) 2002-07-16
EA200401099A1 (ru) 2005-02-24
PA8511401A1 (es) 2002-09-17
NZ520075A (en) 2004-02-27
UA72789C2 (en) 2005-04-15
BG106922A (en) 2003-03-31
GEP20043301B (en) 2004-02-10
NO20023675D0 (no) 2002-08-02
AU2699701A (en) 2001-08-14
ZA200206140B (en) 2003-08-01
UY26568A1 (es) 2001-08-27
AP2002002595A0 (en) 2002-09-30
BR0108002A (pt) 2002-10-29
MA25653A1 (fr) 2002-12-31
JP2003522164A (ja) 2003-07-22
NO20023675L (no) 2002-09-10
EE200200432A (et) 2003-12-15
KR20020072304A (ko) 2002-09-14
TW200804311A (en) 2008-01-16
US20020132810A1 (en) 2002-09-19
US20030204086A1 (en) 2003-10-30
KR20050009776A (ko) 2005-01-25
HK1050006A1 (zh) 2003-06-06
OA12174A (en) 2006-05-09
EA005320B1 (ru) 2005-02-24

Similar Documents

Publication Publication Date Title
PA8467101A1 (es) Compuestos 4-(2-ceto-1-benzilimidazolinil)piperidina como agonistas del receptor orli
PT1193270E (pt) Pirrolobenzodiazepinas
PA8436201A1 (es) Derivados 6,5-heterobiciclicos sustituidos
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
AR006390A1 (es) Derivados de lactama
DK0931788T3 (da) Metalloproteasehæmmere
RS50140B (sr) Postupak za dobijanje perkihinina i njegova upotreba
DK1200418T3 (da) Nematodicide trifluorbutener
ATE260275T1 (de) Substituierte thien-3-yl- sulfonylamino(thio)carbonyl-triazolin(thi)one
BR0109542A (pt) Derivados de imidazopirina alquilados
RS50229B (sr) Analozi vitamina d3
BR0114379A (pt) Derivados de c-ciclohexilmetilamina substituìdos
TR200201128T2 (tr) PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri.
TR200001452T2 (tr) Bifenilamidin türevleri.
DE60112960D1 (de) Kondensierte pyridoindolderivate
DK1305037T3 (da) Smertestillende medikament
ATE333457T1 (de) Zyklische gmp-spezifische phosphodiesteraseinhibitoren
AR027349A1 (es) Derivados de amidas heterociclicas
BR0114380A (pt) Derivados-1-aminobutan-3-ol-substituìdos
BRPI0415034A (pt) derivados de aminopiridina como inibidores de não-sintase induzìveis
HRP20010885B1 (en) Ethanesulfonyl-piperidine derivatives
DE60121048D1 (de) PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE
BR0110490B1 (pt) agentes de tingimento contendo derivados de n-heteroarilmetil-m-fenilenodiamina para fibras de queratina bem como novos derivados de n-heteroarilmetil-m-fenilenodiamina.
UY26574A1 (es) " procedimiento para la separación enzimática de racematos de derivados de aminometil-aril-ciclohexanol".
CO5021190A1 (es) Agentes terapeuticos

Legal Events

Date Code Title Description
FB Suspension of granting procedure